Correlation of loss of CD4 T cells with plasma levels of both soluble form Fas (CD95) and Fas ligand (FasL) in HIV-infected infants

Clinical Immunology

Volumn 95, Issue 1 I, 2000, Pages 20-25

  Hosaka, Naoki ^a   Oyaizu, Naoki ^a   Than, Soe ^a   Pahwa, Savita ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

AIDS HIV; CD4; Infants; Soluble Fas; Soluble Fas ligands

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA SEQUENCE; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0034076929     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4843     Document Type: Article

References (28)

1. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175, 331-340, 1992.
2. Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R. P., and Miedema, F., Programmed death of T cells in HIV-1 infection. Science 257, 217-219, 1992.
3. Oyaizu, N., McCloskey, T. W., Coronesi, M., Chirmule, N., Kalyanaraman, V. S., and Pahwa, S., Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82, 3392-3400, 1993.
4. Nagata, S., Apoptosis by death factor. Cell 88, 355-365, 1997.
5. Cascino, I., Fiucci, G., Papoff, G., and Ruberti, G., Three functional soluble forms of the human apoptosis-inducing fas molecule are produced by alternative splicing. J. Immunol. 154, 2706-2713, 1995.
6. Papoff, G., Cascino, I., Eramo, A., Starace, G., Lynch, D. H., and Ruberti, G., An N-terminal domain shared by Fas/Apo-1 (CD95) soluble variants prevents cell death in vitro. J. Immunol. 156, 4622-4630, 1995.
7. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H., and Nagata, S., Fas ligand in human serum. Nat. Med. 2, 317-322, 1996.
8. Kiener, P. A., Davis, P. M., Rankin, B. M., Klebanoff, S. J., Ledbetter, J. A., Starling, G. C., and Liles, W. C., Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation. J. Immunol. 159, 1594-1598, 1997.
9. Katsikis, P. D., Wunderlich, E. S., Smith, C. A., Herzenberg, L. A., and Herzenberg, L. A., Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036, 1995.
10. Badley, A. D., Dockrell, D. H., Algeciras, A., Ziesmer, S., Landay, A., Lederman, M. M., Connick, E., Kessler, H., Kuritzkes, D., Lynch, D. H., Roche, P., Yagita, H., and Paya, C. V., In vivo analysis of Fas/FasL interaction in HIV-infected patients. J. Clin. Invest. 102, 79-87, 1998.
11. Bäumler, C. B., Böhler, T., Herr, I., Benner, A., Krammer, P. H., and Debatin, K. M., Activation of CD95 (APO-1/Fas) system in T cell from human immunodeficiency virus type-1-infected children. Blood 88, 1741-1746, 1996.
12. Fadeel, B., Samuelsson, A., Hachiya, T., Broström, C., and Chiodi, F., Elevated serum level of soluble Fas/Apo-1 in human immunodeficiency virus-infected individuals. Blood 88, 4727-4730, 1996.
13. Bahr, G. M., Capron, A., Dewulf, J., Nagata, S., Tanaka, M., Bourez, J. M., Mouton, Y., Elevated serum level of Fas ligand with the asymptomatic stage of human immunodeficiency virus infection. Blood 90, 896-898, 1997.
14. Hosaka, N., Oyaizu, N., Kaplan, M. H., Yagita, H., and Pahwa, S., Membrane and soluble forms of Fas (CD95) and Fas ligand in peripheral blood mononuclear cells and in plasma from HIV infected persons. J. Infect. Dis. 178, 1030-1039, 1998.
15. Seishima, M., Takemura, M., Saito, K., Sano, H., Minatoguchi, S., Fujiwara, H., Hachiya, T., Noma, A., Highly sensitive ELISA for soluble Fas in serum: Increased soluble Fas in the elderly. Clin. Chem. 42, 1911-1914, 1996.
16. Miyawaki, T., Uehara, T., Nibu, R., Tsuji, T., Yachie, A., Yonehara, S., and Taniguchi, N., Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149, 3753-3757, 1992.
17. Ascher, M. S., and Sheppard, H. W., AIDS as immune system activation. II. The panergic imnesia hypothesis. J. Acquired Immune Defic. Syndr. 3, 177-191, 1990.
18. Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., El-Khatib, M., Sherr, D. H., Stanger, B. Z., and Marshak-Rothenstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T cell activation. Nature 373, 444-448, 1995.
19. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H., Ikeda, S., Inoue, S., Yoshino, K., Okumura, K., and Yagita, H., Metallo-proteinase-mediated release of human Fas ligand. J. Exp. Med. 182, 1777-1783, 1995.
20. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Ohga, S., Hatake, K., Drummond, A. H., and Nagata, S., Fas ligand in human serum. Nat. Med. 2, 317-322, 1996.
21. + T cells by a Fas-independent mechanism. J. Exp. Med. 187, 1113-1122, 1998.
22. Shearer, G. M., HIV-induced immunopathogenesis. Immunity 9, 587-593, 1998.
23. Oyaizu, N., Adachi, Y., Hashimoto, F., McCloskey, T. W., Hosaka, N., Kayagaki, N., Yagita, H., Pahwa, S., Monocytes express Fas ligand upon CD4 cross-linking and induce T cell apoptosis: A possible mechanism of bystander cell death in HIV infection. J. Immunol. 158, 2456-2463, 1997.
24. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185, 55-64, 1997.
25. Oyaizu, N., Kayagaki, N., Yagita, H., Pahwa, S., and Ikawa, Y., Requirement of cell- cell contact in the induction of Jurkat T cell apoptosis: The membrane-anchored but not soluble form of FasL can trigger anti-CD3-induced apoptosis in Jurkat T cells. Biochem. Biophys. Res. Commun. 238, 670-675, 1998.
26. Suda, T., Hashimoto, H., Masato, T., Oichi, T., and Nagata, S., Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186, 2045-2050, 1997.
27. Tanaka, M., Itai, T., Adachi, M., and Nagata, S., Downregulation of Fas ligand by shedding. Nat. Med. 4, 310-314, 1998.
28. + T cells from human immunodeficiency virus-infected person: Differential in vitro preventive effect of cytokine and protease antagonists. Blood 87, 4959-4966, 1996.